Track the HLB생명과학 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, HLB생명과학 has published 14 reports. Market capitalisation: €261.5bn. The latest transaction was filed on 1 July 2026 (Other). Among the most active insiders: HLB. Every trade is accessible without an account.
14
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,338 of 29,063 companies
17.1
score / 100
Value
19
Quality
16
FCF yld-7.1%
Earn yld-7.6%
EV/EBITDA·
ROE-14%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.